Research Sample bioBank

Can’t find what you’re looking for? Contact us.

Or, need help ordering? 805.528.4341

Filter Samples By:

Get Weekly Research Sample Updates in your Inbox:

Hepatitis B (HBV) Genotype D Clinical Research Samples

Discovery Life Sciences provides the highest quality Hepatitis B (HBV) Genotype D Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank. 

  • All Hepatitis B (HBV) Genotype D Sample Orders are Packaged for Delivery within 24 Hours. 
  • All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
  • Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
  • Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations. 
Showing 58 of 58 total samples
 (0)
Checkout
Advanced Data View:
Showing 58 of 58 total samples
Buy
Product IDSampleOriginMatrixVial (ml)QuantityPriceAgeGenderEthnicityStorage TempSample DateTest 1Test Data 1Sample Detail 1Test 2Test Data 2Sample Detail 2Test 3Test Data 3Sample Detail 3Product
Details
Price
Buy
Additional Information 1Additional Data 1Additional Information 2Additional Data 2Additional Information 3Additional Data 3Additional Information 4Additional Data 4Additional Information 5Additional Data 5Additional Detail 5Additional Information 6Additional Data 6Additional Detail 6Additional Information 7Additional Data 7Additional Detail 7
DLS12-0435Hepatitis B (HBV) Genotype DItalyPlasma0.751.00$95.0050 YMU/A<-70°C11-Apr-13Abbott Realtime PCR697 IU/mLSiemens TruGene HBVD$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryHousehold contactSymptomsFatigue; Itching; NauseaAdditional TestingALT: 890; AST: 1534; ALP: 226; LDH: 1529; Bilirubin: 26.79; Serum Creatinine: 3.64 mg/dL; Hepatocellular carcinoma Hepatitis SerologyHBsAg+; HBeAg-; Anti HBeAg+ (Abbott)
DLS12-7507Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0041 YFU/A<-70°C28-Nov-06Roche cobas2,082 IU/mLHBV Ct Value - 29Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentN/AAcquired Infection Category N/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co+ (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott IMX)
DLS12-7508Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.002.00$40.0043 YMU/A<-70°C23-Aug-07Roche cobas83 IU/mLHBV Ct Value - 31Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentN/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co+ (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott IMX)
DLS12-7514Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0055 YFU/A<-70°C10-Dec-07Roche cobas44 IU/mLHBV Ct Value - 32Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (324) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott IMX)
DLS12-7516Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.002.00$40.0023 YFU/A<-70°C11-Feb-08Roche cobas750 IU/mLHBV Ct Value - 33Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (475) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect)
DLS12-7518Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.252.00$40.0018 YMU/A<-70°C27-May-10Roche cobas662 IU/mLHBV Ct Value - 28Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (613) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-7521Hepatitis B (HBV) Genotype DRussiaCitrated Plasma0.501.00$40.0050 YMU/A<-70°C12-Feb-11Roche cobas52 IU/mLHBV Ct Value - 33Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (182) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-7522Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0034 YMU/A<-70°C29-Dec-11Roche cobas534 IU/mLHBV Ct Value - 30Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (383) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-7525Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.501.00$40.0026 YFU/A<-70°C14-Feb-12Roche cobas21 IU/mLHBV Ct Value - 35Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (282) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-7526Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0045 YMU/A<-70°C03-Mar-12Roche cobas<20 IU/mLHBV Ct Value - 35Innogenetics INNO-LIPAD$40.003-Series HepB Vaccine N/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategorySymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (274) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-7531Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0047 YMU/A<-70°C07-May-12Roche cobas<20 IU/mLHBV Ct Value - 33Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (248) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-8107Hepatitis B (HBV) Genotype DSpainCitrated Plasma0.751.00$40.0030 YMU/A<-70°C29-Sep-12Roche cobas499 IU/mLHBV Ct Value - 31Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (495) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-8108Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.251.00$40.0029 YMU/A<-70°C05-Oct-12Roche cobas502 IU/mLHBV Ct Value - 29Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection Category N/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (570) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-8111Hepatitis B (HBV) Genotype DSpainCitrated Plasma0.251.00$40.0050 YMU/A<-70°C10-Oct-12Roche cobasNot DetectedHBV Ct Value - 34Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / Treatment N/AAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (542) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect) Anti-HBcAg IgM- (Abbott Architect)
DLS12-8482Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0036 YMU/A<-70°C03-Nov-12Viral LoadNot AvailableInnogenetics INNO-LIPAD$40.003-series HepB VaccineUnknownIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co 719.39 (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03343Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.501.00$40.0033 YMU/A< -70C16-Feb-08Roche cobas495 IU/mLHBV Ct Value - 28Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (483) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03345Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.501.00$40.0027 YMU/A< -70C21-Dec-06Roche cobas588 IU/mLHBV Ct Value - 30Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (417) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03354Hepatitis B (HBV) Genotype DSpainCitrated Plasma0.501.00$40.0063 YFU/A< -70C17-Jan-11Roche cobas164 IU/mLHBV Ct Value - 27Innogenetics INNO-LIPAD$40.003- Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (355) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03357Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0028 YMU/A< -70C03-Dec-10Roche cobas430 IU/mLHBV Ct Value - 29Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infections CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (466) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03366Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0027 YMU/A< -70C10-Nov-12Roche cobas32 IU/mLHBV Ct Value - 29Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (531.27) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03369Hepatitis B (HBV) Genotype DSpainCitrated Plasma0.751.00$40.0033 YMU/A< -70C09-Feb-12Roche cobas314 IU/mLHBV Ct Value - 29Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (524) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03372Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0056 YFU/A< -70C11-Apr-11Roche cobas76 IU/mLHBV Ct Value - 28Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (253) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03373Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0042 YMU/A< -70C11-Jan-12Roche cobas42 IU/mLHBV Ct Value - 31Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infections CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (252) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03387Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.501.00$40.0047 YMU/A< -70C25-Jun-11Roche cobas381 IU/mLHBV Ct Value - 27Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (312) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03388Hepatitis B (HBV) Genotype DSpainCitrated Plasma0.751.00$40.0044 YFU/A< -70C11-Jan-13Roche cobas156 IU/mLHBV Ct Value - 30Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (485) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03415Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0050 YFU/A< -70C14-Feb-07Roche cobas61 IU/mLHBV Ct Value - 29Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional Testing N/AHepatitis SerologyHBsAG S/Co (272) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-03417Hepatitis B (HBV) Genotype DSpainCitrated Plasma1.001.00$40.0053 YMU/A< -70C20-Nov-06Roche cobas971 IU/mLHBV Ct Value - 26Innogenetics INNO-LIPAD$40.003-Series HepB VaccineN/AIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryN/ASymptomsAsymptomaticAdditional TestingN/AHepatitis SerologyHBsAG S/Co (224) (Abbott PRISM); Anti-HBcAg (IgG+IgM)+ (Abbott Architect); Anti-HBcAg IgM- (Abbott Architect)
DLS13-11741Hepatitis B (HBV) Genotype DGermanyPlasma1.001.00$95.0035 YMU/A< -70C01-Apr-14Abbott RealTime PCR3,780 IU/mLSequencing In-house AssayD$95.003-series HepB VaccinePartialIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryNeo-natal transmissionSymptomsNoneHepatitis SerologyHBsAg+ (CMIA)Abbott RealTime PCRPositive13-Mar-2018
DLS13-11829Hepatitis B (HBV) Genotype DItalyPlasma1.003.00$95.0060 YFWhite< -70C06-Nov-13Roche cobas80 IU/mLSiemens TruGene HBVD$95.003-Series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsNo symptomsAdditional TestingALT: 16; AST: 17; LDH: 418; Bilirubin: 1.1; Serum Creatinine: 0.5 mg/dL; Grade 1 Stage 2; Chronic Hepatitis Hepatitis SerologyHBsAg-; HBeAg-; HBeAb+; HBcAb+ (CMIA)
DLS13-12210Hepatitis B (HBV) Genotype DFranceCitrated Plasma0.501.00$40.00 U/AU/A< -70C23-Jun-08Roche cobas19 cps/mLGene S Sequencing In-house AssayDMutations: G130R S132YImmuno-Enzymatiqueayw2Serotype$40.00Elisa50.800Prism391.490ConfirmationPosAg Hbe NegativeAc Hbe PositiveHBc Positive
DLS13-12211Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.002.00$40.00 U/AU/A< -70C20-Aug-08Roche cobas7 copies/mLGene S Sequencing In-house AssayDImmuno-Enzymatiquetrop faibleSerotype$40.00Elisa37.852Elisa 29.973ConfirmationPos4eme, 5eme valeur Elisa: 14,095; 13,9526eme, 7eme valeur Elisa: 0,333; 0,349Hepatitis SerologyHBc Positive
DLS13-12228Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.002.00$40.00 U/AU/A< -70C10-Jul-08Roche cobas<6 cps/mLGene S Sequencing In-house AssayD3Immuno-Enzymatiqueayw3Serotype$40.00Elisa54.545Prism382.210ConfirmationPosHBc PositiveHepatitis Serology
DLS13-12242Hepatitis B (HBV) Genotype DFranceCitrated Plasma0.501.00$40.00 U/AU/A< -70C25-May-09Roche cobas1,179 cps/mLGene S Sequencing In-house AssayDImmuno-Enzymatiqueayw2Serotype$40.00Prism656.060Elisa43.246ConfirmationPosHBc PositiveHepatitis SerologyHBc IgM NegativeSyphilis positive : boite 28 : J8
DLS13-12254Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.001.00$40.00 U/AU/A< -70C14-Oct-10Roche cobas392 copies/mLGene S Sequencing In-house AssayD2Immuno-Enzymatiqueayw2Serotype$40.00Prism594.010Elisa50.000DGVPosHBc PositiveHepatitis SerologyAc HBs Positive - Ac Hbe PositiveAgHBe Negative
DLS13-12259Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.001.00$40.00 U/AU/A< -70C11-Jan-11Roche cobas33 copies/mLGene S Sequencing In-house AssayD1Immuno-Enzymatiqueayw2Serotype$40.00Prism420.070Elisa56.727ConfirmationPosDGVPosSyphilis Positive, Ac Hbe PositiveHepatitis SerologyHBc PositiveAg Hbe Negative
DLS13-12262Hepatitis B (HBV) Genotype DFranceCitrated Plasma0.501.00$40.00 U/AU/A< -70C05-Nov-11Roche cobas281 cps/mLGene S Sequencing In-house AssayDImmuno-Enzymatiqueayw2Serotype$40.00Prism564.340Elisa52.117ConfirmationPosDGVPosHBc PositiveHepatitis SerologyAg Hbe NegativeHBc IgM Negative
DLS14-31182Hepatitis B (HBV) Genotype DItalySerum1.003.00$95.0053 YFWhite<-70C05-Mar-16Roche Cobas2,084 IU/mL10-Dec-15Siemens TruGene HBVD10-Dec-15Roche CobasPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsN/AAdditional TestingALT: 21 IU/L; AST: 17 IU/L; Serum Creatinine: 0.74 mg/dL; 25-Nov-2015 ALP: 84 IU/L; Bilirubin: 0.21 mg/dL; Chronic Hepatitis B10-Dec-15Hepatitis SerologyHBsAg+; HBcAb+; HBeAg- HBeAb+; 7-May-2015 | 11/25/2015Co-InfectionsNone
DLS14-31183Hepatitis B (HBV) Genotype DItalySerum1.003.00$95.0064 YMWhite<-70°C08-Oct-15Roche cobas547 IU/mL17-Sep-15Siemens TruGene HBVD17-Sep-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsNoneAdditional TestingALT: 134 U/L; AST: 50 U/L; LDH: 222 U/L; Chronic Active Hepatitis B5-Oct-15Hepatitis SerologyHBsAg+; HBeAb+; HCVAb-21-Sep-15Co-InfectionsN/A
DLS14-31184Hepatitis B (HBV) Genotype DItalySerum1.007.00$95.0059 YMWhite<-70C18-Nov-15Roche Cobas17,600 IU/mL10-Nov-15Siemens TruGene HBVD10-Nov-15Roche CobasPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusion SymptomsN/AAdditional TestingALT: 21 IU/L; AST: 13 IU/L; ALP: 140 IU/L; Bilirubin: 1.1 mg/dL; Serum Creatinine: 1.0 mg/dL; 18-Nov-2015 LDH: 605 IU/L; Chronic Hepatitis9-Dec-15Hepatitis SerologyHBsAg+; HCVAb-; | HBeAb+; HBeAg- 13-Jan-2016 | 1/27/2016Co-InfectionsNone
DLS14-31178Hepatitis B (HBV) Genotype DItalySerum1.004.00$95.0050 YMWhite<-70°C26-Jun-15Roche cobas7,000 IU/mL17-Jun-15Siemens TruGene HBVD17-Jun-15Roche CobasPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsNoneAdditional TestingALT: 68 U/L; AST: 151 U/L; ALP: 53 U/L; LDH: 347 U/L; Bilirubin: 0.6 mg/dL; Serum Creatinine: 1.1; Chronic Hepatitis B18-Dec-14; 17-Jun-15Hepatitis SerologyHBsAg+; HBeAb+18-Dec-14Co-InfectionsN/A
DLS14-31173Hepatitis B (HBV) Genotype DItalySerum1.003.00$95.0047 YMWhite<-70C17-May-16Roche Cobas826 IU/mL20-Apr-16Siemens TruGene HBVD20-Apr-16Roche CobasPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryAlcohol and IV Drug Abuse SymptomsN/AAdditional TestingALT: 36 IU/L; AST: 21 IU/L; Bilirubin: 0.21 mg/dL; Chronic Hepatitis B15-Apr-16Hepatitis SerologyHBsAg+; HBeAb+; HBcAb+; | HCVAb-; 20-Apr-2016 | 15-Feb-2016 Co-InfectionsNone
DLS14-31185Hepatitis B (HBV) Genotype DItalySerum1.004.00$95.0064 YMWhite<-70°C13-Oct-15Roche cobas60 IU/mL7-Oct-15Siemens TruGene HBVD7-Oct-15Roche CobasPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusionSymptomsNoneAdditional TestingALT: 67 U/L; AST: 41 U/L; LDH: 148 U/L; Bilirubin: 0.3 mg/dL; Serum Creatinine: 0.3; Chronic Active Hepatitis B7-Oct-15Hepatitis SerologyHBsAg+; HBeAb+; HCVAb-28-Sep-15Co-InfectionsN/A
DLS14-31187Hepatitis B (HBV) Genotype DItalySerum1.008.00$95.0068 YFWhite<-70C03-Oct-16Roche CobasNegative3-Oct-16Siemens TruGene HBVD3-Oct-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsN/AAdditional TestingALT: 18 IU/L; AST: 10 IU/L; LDH: 175 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.7 mg/dL; Chronic Hepatitis B3-Oct-16Hepatitis SerologyHBsAg+; HBeAb+; HBcAb+; HCVAb-; 3-Oct-16Co-InfectionsNone
DLS14-31193Hepatitis B (HBV) Genotype DItalySerum1.002.00$95.0077 YMWhite<-70°C03-Feb-15Roche cobas1,220 IU/mL9-Feb-15Siemens TruGene HBVD9-Feb-15$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknownSymptomsNoneAdditional TestingALT: 45 U/L; AST: 58 U/L; Bilirubin: 0.59 mg/dL; Serum Creatinine: 0.7; Chronic Active Hepatitis B9-Feb-15Hepatitis SerologyHBsAg+; HBsAb-; HBeAg-9-Feb-15Co-InfectionsN/A
DLS14-31194Hepatitis B (HBV) Genotype DItalySerum1.005.00$95.0063 YMWhite<-70C05-Oct-16Roche COBAS AmpliPrep 5,080 IU/mL27-Sep-16Siemens TruGene HBVGenotype D27-Sep-16Roche COBAS AmpliPrepPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNoneAdditional TestingALT: 53 IU/L; AST: 10 IU/L; LDH: 225 IU/L; Bilirubin: 0.3 mg/dL; Serum Creatinine: 0.7 mg/dL; Chronic Hepatitis B 27-Sep-2016 Hepatitis SerologyHBsAg+ HBeAg- HBC+ HCVAb- 8-Aug-2016 (CMIA) Co-InfectionsNone
DLS16-72178Hepatitis B (HBV) Genotype DItalySerum1.0014.00$95.0042 YFWhite<-70C24-Oct-16Roche COBAS AmpliPrepNegative24-Oct-16Siemens TruGene HBVGenotype D24-Oct-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNoneAdditional TestingALT: 14 IU/L; AST: 12 IU/L; LDH: 148 IU/L; Bilirubin: 0.6 mg/dL; Serum Creatinine: 0.6 mg/dL; Chronic Hepatitis B 24-Oct-2016Hepatitis SerologyHBsAg+ HBeAb+ HBcAb+ HBeAg- 24-Oct-2016 (CMIA) Co-InfectionsNone
DLS16-72179Hepatitis B (HBV) Genotype DItalySerum1.002.00$95.0063 YMWhite<-70C30-Nov-16Roche COBAS AmpliPrep 245,000 IU/mL21-Nov-16Siemens TruGene HBVGenotype D21-Nov-16Roche COBAS AmpliPrepPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategorySexual TransmissionSymptomsNoneAdditional TestingALT: 40 IU/L; AST: 41 IU/L; Bilirubin: 0.4 mg/dL; Serum Creatinine: 0.9 mg/dL; Liver Cirrhosis3-Oct-2016 Hepatitis SerologyHBsAg+ HCVAb- HBcAb+ HBsAb- 3-Oct-2016 (CMIA) Co-InfectionsNone
DLS16-72181Hepatitis B (HBV) Genotype DItalySerum1.003.00$95.0076 YFWhite<-70C17-Oct-16Roche Cobas20 IU/mL17-Nov-16Siemens TruGene HBVD20-Oct-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsN/AAdditional TestingALT: 26 IU/L; AST: 26 IU/L; LDH: 216 IU/L; Bilirubin: 0.6 mg/dL; Serum Creatinine: 0.8 mg/dL; Chronic Hepatitis B17-Oct-16Hepatitis SerologyHBsAg+; HBeAb+; HBcAb+; HBeAg- 17-Oct-2016 Co-InfectionsNone
DLS16-72182Hepatitis B (HBV) Genotype DItalySerum1.009.00$95.0059 YFWhite<-70C06-Dec-16Roche Cobas1,980 IU/mL10-Jan-17Siemens TruGene HBVD10-Jan-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryTransfusion SymptomsN/AAdditional TestingALT: 14 IU/L; AST: 15 IU/L; Bilirubin: 0.3 mg/dL; Serum Creatinine: 0.8 mg/dL; Chronic Active Hepatitis B15-Nov-16Hepatitis SerologyHBsAg+; HBsAb+ HBcAb+; HCVAb-; 15-Nov-16Co-InfectionsNone
DLS16-72190Hepatitis B (HBV) Genotype DItalySerum1.004.00$95.0074 YMWhite<-70C02-Feb-17Roche Cobas46.6 IU/mL23-Jan-17Siemens TruGene HBVD23-Jan-17$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryUnknown SymptomsN/AAdditional TestingALT: 14 IU/L; AST: 14 IU/L; Bilirubin: 0.6 mg/dL; Serum Creatinine: 1.1 mg/dL; Chronic Active Hepatitis B23-Jan-17Hepatitis SerologyHBsAg+; HBeAg- HCVAb-; 23-Jan-17Co-InfectionsNone
DLS16-72192Hepatitis B (HBV) Genotype DItalySerum1.004.00$95.0043 YMWhite<-70C17-Oct-16Roche COBAS AmpliPrep 1,140 IU/mL6-Oct-16Siemens TruGene HBVGenotype D6-Oct-16Roche COBAS AmpliPrepPositive13-Mar-2018$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNoneAdditional TestingALT: 56 IU/L; AST: 32 IU/L; Bilirubin: 0.8 mg/dL; Serum Creatinine: 0.8 mg/dL; Chronic Hepatitis B6-Oct-2016Hepatitis SerologyHBsAg+ HBcAb+ HBeAb+ HCVAb- 6-Oct-2016 (CMIA) Co-InfectionsNone
DLS16-72193Hepatitis B (HBV) Genotype DItalySerum1.0011.00$95.0037 YMWhite<-70C14-Nov-16Roche COBAS AmpliPrep 20 IU/mL14-Nov-16Siemens TruGene HBVGenotype D16-Nov-16$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/ASymptomsNoneAdditional TestingALT: 27 IU/L; AST: 14 IU/L; LDH: 145 IU/L; Bilirubin: 0.3 mg/dL; Serum Creatinine: 0.6 mg/dL; Chronic Active Hepatitis B14-Nov-2016 Hepatitis SerologyHBsAg+ HBcAb+ HBeAb+ HCVAb- 14-Nov-2016 (CMIA) Co-InfectionsNone
DLS17-038201Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.005.00$40.00 U/AU/A<-70C03-May-12Roche cobas88,167,700 IU/mLGene S Sequencing In-house AssayD8Enzyme immunoassayayw2Serotype$40.00HBsAg Titer192,000 ng/mLPrism318.700 | 347.590 | 320.320Elisa30.500ConfirmationPosDGV UltrioPosHepatitis SerologyHBc Positive, HBeAg Positive
DLS17-038202Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.005.00$40.00 U/AU/A<-70CRoche cobas1,543,655 IU/mLGene S Sequencing In-house AssayDEnzyme immunoassayayw2Serotype$40.00HBsAg Titer96,000 ng/mLPrism552.060 | 515.640 | 522.470Elisa50.847ConfirmationPosHepatitis SerologyHBe Positive
DLS17-038203Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.007.00$40.00 U/AU/A<-70C22-Sep-10Roche cobas2,811,723 IU/mLGene S Sequencing In-house AssayD2Enzyme immunoassayayw2Serotype$40.00HBsAg Titer96,000 ng/mLPrism641.140 | 543.020 | 530.410Axsym120.630ConfirmationPosHepatitis SerologyHbc Positive, HBsAg Positive, HBe Positive
DLS17-038209Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.005.00$40.00 U/AU/A<-70C08-Sep-11Roche cobas13,961,137 IU/mLGene S Sequencing In-house AssayD1Enzyme immunoassayayw2Serotype$40.00HBsAg Titer96,000 ng/mLElisa50.847 | 49.180 | 50.847Prism494.030DGVPosMutationP120THepatitis SerologyHBc Positive, HBe Positive
DLS17-038215Hepatitis B (HBV) Genotype DFranceCitrated Plasma1.008.00$40.00 U/AU/A<-70C24-Aug-12Roche cobas8,589,305 IU/mLGene S Sequencing In-house AssayD2Enzyme immunoassayayw3Serotype$40.00HBsAg Titer192,000 ng/mLPrism385.800 | 444.870 | 423.080Elisa39.571DGV UltrioPosHepatitis SerologyHBc Positive
DLS0025522Hepatitis B (HBV) Genotype DItalySerum1.0011.00$95.0051 MWhite<-70C10-Jan-18Roche Cobas Ampliprep1,100,000 IU/mLSiemens TruGene HBVGenotype D$95.003-series HepB VaccineNoIs Subject on Anti-Viral Therapy / TreatmentNoAcquired Infection CategoryU/A | ItalySymptomsNoneAdditional TestingALT: 56 IU/L | Creatinine: 1.5 mg/dL | Chronic Hepatitis B 20-Dec-17Serology ResultsHBsAg+ | HBcAb-20-Dec-17

Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.

Please read carefully before purchasing:

Clinical specimens for research use only.

Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.

If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341

These products are supplied without warranty for suitability for specific applications or analytical determinations.

Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.